Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost/Timolol preservative-free vs GANFORT in glaucoma or ocular hypertension
2010-021507-24Phase 3Completed
- Sponsor
- Allergan
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bimatoprost + timolol in Glaucoma, ocular hypertension and chronic angle-closure glaucoma (CACG) (2 arms), sponsored by Allergan. Primary endpoint: Primary IOP-lowering effect. Started Sep 2010; status: completed.
02
Drugs
bimatoprost + timolol
03
Conditions
Glaucomaocular hypertensionchronic angle-closure glaucoma (CACG)
Beyond the preview
Go deeper on 2010-021507-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021507-24.